MesoTV Podcast: Conversations Impacting the Mesothelioma Community
6 FOLLOWERS
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment,..
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1M ago
Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine. She discusses biomarker information, such as histology (currently most valuable), but also molecular testing such as NF2, MTAP, CDKN2A mutations that can be used when determining precision medicine treatments. Other topics discussed are BAP1 mutations, PDL1 expression, mutational burden, and oncolytic viruses. The interview is moderated by Julie White, BSN, OCN, RN who is the patient services director at the Mesothelioma Applied Research Foundation. More information is available at cur ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
3M ago
Michael Offin, MD, MSKCC, joins us for an informative session about chemotherapy drugs, their uses, side effects, and supportive medications ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
Andreas Rimner, MD, Memorial Sloan Kettering Cancer Center, joins us for a conversation about radiation oncology and currently available clinical trials. He discussed various ways patients can benefit from radiation therapy, including an overview of different types of radiation and different modes of treatment. Radiation therapy can be applied alone, or in combination with other treatments such as surgery, chemotherapy, or immunotherapy. Dr. Rimner is a radiation oncologist who specializes in caring for people with cancers of the chest, known as thoracic cancers. These include non-small cell a ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
Dr. Andrea Wolf is Director of the New York Mesothelioma Program at the Mount Sinai Health System, which provides comprehensive, multidisciplinary clinical care for patients with suspected or diagnosed malignant pleural mesothelioma. She has expertise in surgery for pleural mesothelioma and VATS lobectomy, and research interests in mesothelioma, health care disparities, and lung cancer. Dr. Wolf graduated Cum Laude from Princeton University and earned highest honors and her medical degree at Harvard Medical School. She trained in General Surgery and served as Chief Resident at Massachusetts Ge ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
Conversation with Travis Grotz, MD, surgical oncologist at Mayo Clinic who specializes in the treatment of peritoneal malignancies. Dr. Grotz serves on the Science Advisory Board of the Mesothelioma Applied Research Foundation. He is interviewed by Shannon Sinclair, RN, BSN, OCN, who serves as the patient services director at the Mesothelioma Applied Research Foundation. www.curemeso.org ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
We meet with Dr. Joseph Friedberg, a thoracic surgeon at Temple University Hospital-Main Campus and Fox Chase Cancer Center. Joseph Friedberg, MD, FACS, is Thoracic Surgeon-in-Chief of Temple University Health System, Vice Chair of Surgical Services for the Department of Thoracic Medicine and Surgery, Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, and Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. He is interviewed by Shannon Sinclair, RN, BSN, OCN, who serves as the patient services director at the Mesothelioma ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
Separately, chemotherapy and immunotherapy are both approved to treat mesothelioma, and individually they work equally well for those patients with the epithelioid type of disease. Currently, the question in front of scientists is what happens when those two treatments are combined? DREAMER, a new clinical trial enrolling right now in the United States and Australia, is looking to find those answers. In this episode of MesoTV we talk with one of the principal investigators of this study, Dr. Patrick Forde of Johns Hopkins, to ask him about what this trial means to patients. If a patients is co ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
The Mesothelioma Applied Research Foundation can help guide you through the selection of medical specialists and treatments including clinical trials. Our on-staff mesothelioma expert, Shannon Sinclair, RN, BSN, OCN, is available to speak with patients and their families to help guide them through their diagnosis and treatment options. She can be reached at shannon@curemeso.org or by phone at (703) 879-3821. Shannon is an oncology nurse with 14 years of experience working at a large cancer center in Ohio where she worked with a multidisciplinary team comprised of medical and radiation oncologi ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
We are joined by Dr. Marjorie Zauderer, a medical oncologist at Memorial Sloan Kettering Cancer Center. Dr. Zauderer talks to us about the thought process she and other medical oncologists employ when determining whether a patient should enroll in a clinical trial and which trial that should be ..read more
MesoTV Podcast: Conversations Impacting the Mesothelioma Community
1y ago
In this episode, we are joined by two patients who recently received a mesothelioma diagnosis. They discuss their initial shock to hear the word "mesothelioma" and their subsequent efforts to find specialists experienced in treating their cancer ..read more